148 related articles for article (PubMed ID: 38536518)
1. Prognostic modeling in early rheumatoid arthritis: reconsidering the predictive role of disease activity scores.
Bird A; Oakden-Rayner L; Smith LA; Zeng M; Ray S; Proudman S; Palmer LJ
Clin Rheumatol; 2024 May; 43(5):1503-1512. PubMed ID: 38536518
[TBL] [Abstract][Full Text] [Related]
2. Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database.
Ranganath VK; Paulus HE; Onofrei A; Khanna D; Reed G; Elashoff DA; Kremer JM; Furst DE
J Rheumatol; 2008 Oct; 35(10):1966-71. PubMed ID: 18785317
[TBL] [Abstract][Full Text] [Related]
3. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
[TBL] [Abstract][Full Text] [Related]
4. Disability measured by the modified health assessment questionnaire in early rheumatoid arthritis: prognostic factors after two years of follow-up.
Graell E; Vazquez I; Larrosa M; Rodríguez-Cros JR; Hernández MV; Gratacós J; Gómez A; Cañete JD; Gómez-Puerta JA; Sanmartí R
Clin Exp Rheumatol; 2009; 27(2):284-91. PubMed ID: 19473570
[TBL] [Abstract][Full Text] [Related]
5. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis.
Gerber LH; Furst G; Yarboro C; el-Gabalawy H
Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S65-70. PubMed ID: 14969053
[TBL] [Abstract][Full Text] [Related]
6. Tender Joint Count and Inflammatory Activity in Patients With Established Rheumatoid Arthritis: Results From a Longitudinal Study.
Hammer HB; Michelsen B; Provan SA; Sexton J; Lampa J; Uhlig T; Kvien TK
Arthritis Care Res (Hoboken); 2020 Jan; 72(1):27-35. PubMed ID: 30474932
[TBL] [Abstract][Full Text] [Related]
7. Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis.
Bertsias A; Flouri ID; Repa A; Avgoustidis N; Kalogiannaki E; Pitsigavdaki S; Bertsias G; Sidiropoulos P
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38242549
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal predictive ability of mapping models: examining post-intervention EQ-5D utilities derived from baseline MHAQ data in rheumatoid arthritis patients.
Kontodimopoulos N; Bozios P; Yfantopoulos J; Niakas D
Eur J Health Econ; 2013 Apr; 14(2):307-14. PubMed ID: 22252308
[TBL] [Abstract][Full Text] [Related]
9. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year.
Kay J; Morgacheva O; Messing SP; Kremer JM; Greenberg JD; Reed GW; Gravallese EM; Furst DE
Arthritis Res Ther; 2014 Feb; 16(1):R40. PubMed ID: 24485007
[TBL] [Abstract][Full Text] [Related]
10. Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort.
Choy T; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
Rheumatology (Oxford); 2014 Mar; 53(3):482-90. PubMed ID: 24241035
[TBL] [Abstract][Full Text] [Related]
11. A multicentre observational study comparing patient reported outcomes to assess reliability of swollen and tender joint assessments and response to certolizumab treatment as compared to clinician assessments in rheumatoid arthritis.
Inderjeeth CA; Inderjeeth AJ; Raymond WD
Int J Rheum Dis; 2019 Jan; 22(1):73-80. PubMed ID: 30187688
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions.
Castrejón I; Dougados M; Combe B; Fautrel B; Guillemin F; Pincus T
J Rheumatol; 2016 Jul; 43(7):1285-91. PubMed ID: 27084913
[TBL] [Abstract][Full Text] [Related]
13. Effect of early treatment on physical function in daily management of rheumatoid arthritis: a 5-year longitudinal study of rheumatoid arthritis patients in the National Database of Rheumatic Diseases in Japan.
Hirata A; Suenaga Y; Miyamura T; Matsui T; Tohma S; Suematsu E; Ohnaka K; Takayanagi R
Int J Rheum Dis; 2018 Apr; 21(4):828-835. PubMed ID: 27126059
[TBL] [Abstract][Full Text] [Related]
14. Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews.
Archer R; Hock E; Hamilton J; Stevens J; Essat M; Poku E; Clowes M; Pandor A; Stevenson M
Health Technol Assess; 2018 Nov; 22(66):1-294. PubMed ID: 30501821
[TBL] [Abstract][Full Text] [Related]
15. Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis.
Hammer HB; Michelsen B; Sexton J; Uhlig T; Provan SA
Clin Rheumatol; 2021 May; 40(5):1739-1749. PubMed ID: 33040226
[TBL] [Abstract][Full Text] [Related]
16. Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis.
Doumen M; De Cock D; Pazmino S; Bertrand D; Joly J; Westhovens R; Verschueren P
Arthritis Res Ther; 2021 Oct; 23(1):269. PubMed ID: 34706771
[TBL] [Abstract][Full Text] [Related]
17. Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?
Soubrier M; Zerkak D; Gossec L; Ayral X; Roux C; Dougados M
J Rheumatol; 2006 Jul; 33(7):1243-6. PubMed ID: 16622906
[TBL] [Abstract][Full Text] [Related]
18. Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivity.
Smolen JS; Strand V; Koenig AS; Szumski A; Kotak S; Jones TV
Arthritis Res Ther; 2016 May; 18(1):114. PubMed ID: 27209012
[TBL] [Abstract][Full Text] [Related]
19. Association Between Baseline Anti-cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients with RA.
Harrold LR; Bryson J; Lehman T; Zhuo J; Gao S; Han X; Schrader A; Rebello S; Pappas DA; Sommers T; Kremer JM
Rheumatol Ther; 2021 Jun; 8(2):937-953. PubMed ID: 34047953
[TBL] [Abstract][Full Text] [Related]
20. Twenty-Year Outcome and Association Between Early Treatment and Mortality and Disability in an Inception Cohort of Patients With Rheumatoid Arthritis: Results From the Norfolk Arthritis Register.
Gwinnutt JM; Symmons DPM; MacGregor AJ; Chipping JR; Marshall T; Lunt M; Verstappen SMM
Arthritis Rheumatol; 2017 Aug; 69(8):1566-1575. PubMed ID: 28425173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
